S&P 500 7,588.05 ▲ 34.37 (+0.46%) DOW 51,590.87 ▲ 903.80 (+1.78%) NASDAQ 26,845.01 â–ŧ 8.96 (-0.03%) US Markets Closed â€ĸ 05:41 PM ET

VERO

Venus Concept Inc.

Price Chart

No historical data available

Latest Quote

$0.31

+0.01 (+2.64%)
Current Price
Previous Close $0.30
Open $0.27
Day High $0.27
Day Low $0.27
Volume 43
Fetched: 2026-06-04T21:41:41
Stock Information
Shares Outstanding 1.86M
Total Debt $32.67M
Cash Equivalents $4.31M
Revenue $58.88M
Net Income $-54.61M
Sector Healthcare
Industry Medical Devices
Market Cap $578K
EPS (TTM) $-45.26
Exchange PNK
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$29.38M
Sales$58.88M
Income$-54.61M
Book/sh$1.44
Cash/sh$2.32
Employees292
Financial Ratios
Quick Ratio0.42
Current Ratio0.91
Debt/Eq1042.31
Returns & Margins
ROA-32.43%
ROE-794.55%
Gross Margin64.36%
Operating Margin-68.93%
Profit Margin-92.76%
Ownership
Insider Ownership0.82%
Institutional Ownership14.59%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-0.14
P/S0.01
P/B0.22
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.34
SMA50$0.59
SMA200$1.82
RSI50.14
ATR0.0791
Shares Float1.62M
Short Float12.47%
Short Ratio0.05
Volatility-0.06
Rel Volume0.10
Performance History
Week-7.72%
Month-30.89%
Quarter-79.54%
6 Months-87.15%
YTD-79.54%
Year-86.24%
3 Years-99.18%
5 Years-99.92%
10 Years-100.00%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
No history data available. Data will be fetched automatically.
About Venus Concept Inc.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Reconciled Cost Of Revenue $20,527,000 $24,187,000 $33,526,000 $31,528,000
Cost Of Revenue $20,527,000 $24,187,000 $33,526,000 $31,528,000
Total Revenue $64,833,000 $76,354,000 $99,497,000 $105,622,000
Operating Revenue $64,833,000 $76,354,000 $99,497,000 $105,622,000
Expenses
Interest Expense $7,656,000 $6,893,000 $4,561,000 $4,955,000
Total Expenses $92,017,000 $104,663,000 $134,373,000 $123,164,000
Rent Expense Supplemental $3,249,000 $4,312,000 $9,435,000 $10,459,000
Other Income Expense $-12,742,000 $-1,919,000 $-4,869,000 $-351,000
Net Non Operating Interest Income Expense $-7,656,000 $-6,893,000 $-4,561,000 $-4,955,000
Interest Expense Non Operating $7,656,000 $6,893,000 $4,561,000 $4,955,000
Operating Expense $71,490,000 $80,476,000 $100,847,000 $91,636,000
Selling And Marketing Expense $28,332,000 $31,231,000 $40,276,000 $41,920,000
General And Administrative Expense $36,470,000 $41,048,000 $49,618,000 $40,070,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-46,996,000 $-37,250,000 $-43,700,000 $-23,013,000
Net Interest Income $-7,656,000 $-6,893,000 $-4,561,000 $-4,955,000
Normalized Income $-34,417,620 $-35,334,670 $-38,910,344 $-22,672,861
Net Income From Continuing And Discontinued Operation $-46,996,000 $-37,250,000 $-43,700,000 $-23,013,000
Total Operating Income As Reported $-27,184,000 $-28,309,000 $-34,876,000 $-14,767,000
Net Income Common Stockholders $-46,996,000 $-37,250,000 $-43,700,000 $-23,013,000
Net Income $-46,996,000 $-37,250,000 $-43,700,000 $-23,013,000
Net Income Including Noncontrolling Interests $-46,971,000 $-37,050,000 $-43,584,000 $-22,141,000
Net Income Continuous Operations $-46,971,000 $-37,050,000 $-43,584,000 $-22,141,000
Pretax Income $-47,582,000 $-37,121,000 $-44,306,000 $-22,848,000
Special Income Charges $-11,378,000 $-2,214,000 $-1,482,000 $2,208,000
Operating Income $-27,184,000 $-28,309,000 $-34,876,000 $-17,542,000
Gross Profit $44,306,000 $52,167,000 $65,971,000 $74,094,000
Per Share
Diluted EPS $-71.21 $-68.47 $-108.90 $-69.30
Basic EPS $-71.21 $-68.47 $-108.90 $-69.30
Other
Tax Effect Of Unusual Items $-163,620 $-3,670 $-79,344 $-10,861
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-23,295,000 $-24,194,000 $-30,413,000 $-12,688,000
Total Unusual Items $-12,742,000 $-1,919,000 $-4,869,000 $-351,000
Total Unusual Items Excluding Goodwill $-12,742,000 $-1,919,000 $-4,869,000 $-351,000
Reconciled Depreciation $3,889,000 $4,115,000 $4,463,000 $4,854,000
EBITDA (Bullshit earnings) $-36,037,000 $-26,113,000 $-35,282,000 $-13,039,000
EBIT $-39,926,000 $-30,228,000 $-39,745,000 $-17,893,000
Diluted Average Shares $659,999 $543,999 $399,757 $330,096
Basic Average Shares $659,999 $543,999 $399,757 $330,096
Diluted NI Availto Com Stockholders $-46,996,000 $-37,250,000 $-43,700,000 $-23,013,000
Minority Interests $-25,000 $-200,000 $-116,000 $-872,000
Tax Provision $-611,000 $-71,000 $-722,000 $-707,000
Gain On Sale Of Business $-23,000 $-174,000 $-1,482,000 $-567,000
Other Special Charges $11,355,000 $2,040,000 - $-2,775,000
Gain On Sale Of Security $-1,364,000 $295,000 $-3,387,000 $-2,559,000
Research And Development $6,688,000 $8,197,000 $10,953,000 $9,646,000
Selling General And Administration $64,802,000 $72,279,000 $89,894,000 $81,990,000
Other Gand A $36,470,000 $41,048,000 $49,618,000 $40,070,000
Otherunder Preferred Stock Dividend - - - $0
Impairment Of Capital Assets - - - $0
Fetched: 2026-02-07
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $-2,604,000 $-22,465,000 $-3,826,000 $25,550,000
Total Assets $68,184,000 $93,654,000 $125,378,000 $157,372,000
Total Non Current Assets $19,672,000 $27,208,000 $41,370,000 $46,873,000
Non Current Deferred Assets $1,459,000 $1,032,000 $947,000 $284,000
Non Current Deferred Taxes Assets $1,459,000 $1,032,000 $947,000 $284,000
Non Current Accounts Receivable $8,534,000 $11,318,000 $20,044,000 $27,710,000
Goodwill And Other Intangible Assets $4,973,000 $8,446,000 $11,919,000 $15,393,000
Other Intangible Assets $4,973,000 $8,446,000 $11,919,000 $15,393,000
Current Assets $48,512,000 $66,446,000 $84,008,000 $110,499,000
Other Current Assets $495,000 $504,000 $1,170,000 $808,000
Prepaid Assets $6,855,000 $6,902,000 $7,569,000 $8,404,000
Inventory $17,561,000 $23,072,000 $23,906,000 $20,543,000
Receivables $19,330,000 $30,572,000 $39,493,000 $49,645,000
Other Receivables $49,000 $85,000 $629,000 $1,405,000
Taxes Receivable $560,000 $1,336,000 $1,602,000 $1,322,000
Accounts Receivable $18,721,000 $29,151,000 $37,262,000 $46,918,000
Allowance For Doubtful Accounts Receivable $-3,402,000 $-7,338,000 $-13,619,000 $-11,997,000
Gross Accounts Receivable $22,123,000 $36,489,000 $50,881,000 $58,915,000
Cash Cash Equivalents And Short Term Investments $4,271,000 $5,396,000 $11,569,000 $30,876,000
Cash And Cash Equivalents $4,271,000 $5,396,000 $11,569,000 $30,876,000
Current Deferred Assets - $1,000 $301,000 $223,000
Debt
Net Debt $35,437,000 $69,549,000 $66,169,000 $46,992,000
Total Debt $43,027,000 $79,697,000 $83,766,000 $77,868,000
Long Term Debt And Capital Lease Obligation $33,434,000 $73,952,000 $74,224,000 $77,325,000
Long Term Debt $31,437,000 $70,790,000 $70,003,000 $77,325,000
Current Debt And Capital Lease Obligation $9,593,000 $5,745,000 $9,542,000 $543,000
Current Debt $8,271,000 $4,155,000 $7,735,000 $543,000
Other Current Borrowings - $4,155,000 $7,735,000 $543,000
Liabilities
Total Liabilities Net Minority Interest $65,346,000 $107,103,000 $116,640,000 $115,776,000
Total Non Current Liabilities Net Minority Interest $35,059,000 $75,944,000 $77,045,000 $81,056,000
Other Non Current Liabilities $511,000 $338,000 $215,000 $348,000
Non Current Deferred Liabilities $364,000 $686,000 $957,000 $1,401,000
Non Current Deferred Taxes Liabilities $0 $15,000 $0 $46,000
Current Liabilities $30,287,000 $31,159,000 $39,595,000 $34,720,000
Current Deferred Liabilities $1,860,000 $2,544,000 $4,162,000 $4,708,000
Current Notes Payable $8,271,000 $0 - -
Payables And Accrued Expenses $18,834,000 $22,870,000 $25,891,000 $29,469,000
Payables $8,933,000 $13,272,000 $13,767,000 $15,341,000
Total Tax Payable $2,449,000 $4,234,000 $5,734,000 $6,923,000
Income Tax Payable $0 $366,000 $117,000 $294,000
Accounts Payable $6,484,000 $9,038,000 $8,033,000 $8,418,000
Tradeand Other Payables Non Current - $0 $374,000 $563,000
Equity
Common Stock Equity $2,369,000 $-14,019,000 $8,093,000 $40,943,000
Total Equity Gross Minority Interest $2,838,000 $-13,449,000 $8,738,000 $41,596,000
Stockholders Equity $2,369,000 $-14,019,000 $8,093,000 $40,943,000
Retained Earnings $-308,899,000 $-261,903,000 $-224,105,000 $-180,405,000
Other
Ordinary Shares Number $709,129 $502,649 $467,426 $387,773
Share Issued $709,129 $502,649 $467,426 $387,773
Tangible Book Value $-2,604,000 $-22,465,000 $-3,826,000 $25,550,000
Invested Capital $42,077,000 $60,926,000 $85,831,000 $118,811,000
Working Capital $18,225,000 $35,287,000 $44,413,000 $75,779,000
Capital Lease Obligations $3,319,000 $4,752,000 $6,028,000 $0
Total Capitalization $33,806,000 $56,771,000 $78,096,000 $118,268,000
Minority Interest $469,000 $570,000 $645,000 $653,000
Additional Paid In Capital $311,238,000 $247,854,000 $232,169,000 $221,321,000
Capital Stock $30,000 $30,000 $29,000 $27,000
Common Stock $30,000 $30,000 $29,000 $27,000
Employee Benefits $528,000 $634,000 $867,000 $911,000
Non Current Pension And Other Postretirement Benefit Plans $528,000 $634,000 $867,000 $911,000
Non Current Accrued Expenses $222,000 $334,000 $408,000 $508,000
Non Current Deferred Revenue $364,000 $671,000 $957,000 $1,355,000
Long Term Capital Lease Obligation $1,997,000 $3,162,000 $4,221,000 $0
Current Deferred Revenue $1,860,000 $2,544,000 $4,162,000 $4,708,000
Current Capital Lease Obligation $1,322,000 $1,590,000 $1,807,000 $0
Current Accrued Expenses $9,901,000 $9,598,000 $12,124,000 $14,128,000
Defined Pension Benefit $488,000 $573,000 $741,000 $817,000
Net PPE $4,218,000 $5,839,000 $7,719,000 $2,669,000
Accumulated Depreciation $-6,659,000 $-6,281,000 $-5,690,000 $-11,197,000
Gross PPE $10,877,000 $12,120,000 $13,409,000 $13,866,000
Leases $752,000 $854,000 $794,000 $1,839,000
Other Properties $8,045,000 $9,087,000 $10,432,000 $8,308,000
Machinery Furniture Equipment $2,080,000 $2,179,000 $2,183,000 $3,719,000
Properties $0 $0 $0 $0
Finished Goods $14,254,000 $19,075,000 $19,316,000 $16,526,000
Work In Process $1,658,000 $2,048,000 $2,112,000 $1,649,000
Raw Materials $1,649,000 $1,949,000 $2,478,000 $2,368,000
Long Term Provisions - - $408,000 $508,000
Current Provisions - - $1,074,000 $1,245,000
Duefrom Related Parties Current - - $629,000 $1,405,000
Fetched: 2026-02-07
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $-11,189,000 $-12,975,000 $-27,316,000 $-20,283,000
Operating Activities
Operating Cash Flow $-11,066,000 $-12,859,000 $-26,980,000 $-19,771,000
Cash Flow From Continuing Operating Activities $-11,066,000 $-12,859,000 $-26,980,000 $-19,771,000
Operating Gains Losses $11,471,000 $2,224,000 $158,000 $-2,208,000
Investing Activities
Capital Expenditure $-123,000 $-116,000 $-336,000 $-512,000
Investing Cash Flow $-123,000 $-116,000 $-336,000 $-552,000
Cash Flow From Continuing Investing Activities $-123,000 $-116,000 $-336,000 $-552,000
Financing Activities
Issuance Of Capital Stock $987,000 $7,077,000 $8,653,000 $16,740,000
Financing Cash Flow $10,064,000 $6,802,000 $8,009,000 $16,819,000
Cash Flow From Continuing Financing Activities $10,064,000 $6,802,000 $8,009,000 $16,819,000
Net Other Financing Charges $-126,000 $-275,000 $-124,000 $-440,000
Net Common Stock Issuance $987,000 $7,077,000 $8,653,000 $16,740,000
Common Stock Issuance $987,000 $7,077,000 $8,653,000 $16,740,000
Other
Issuance Of Debt $9,203,000 $0 - $0
Interest Paid Supplemental Data $1,610,000 $4,473,000 $4,147,000 $3,292,000
Income Tax Paid Supplemental Data $128,000 $124,000 $329,000 $116,000
End Cash Position $4,271,000 $5,396,000 $11,569,000 $30,876,000
Beginning Cash Position $5,396,000 $11,569,000 $30,876,000 $34,380,000
Changes In Cash $-1,125,000 $-6,173,000 $-19,307,000 $-3,504,000
Net Issuance Payments Of Debt $9,203,000 $0 $-543,000 $-738,000
Net Short Term Debt Issuance $7,596,000 $0 - $0
Short Term Debt Issuance $7,596,000 $0 - -
Net Long Term Debt Issuance $1,607,000 $0 $-543,000 $-738,000
Long Term Debt Issuance $1,607,000 $0 - $0
Net PPE Purchase And Sale $-123,000 $-116,000 $-336,000 $-512,000
Purchase Of PPE $-123,000 $-116,000 $-336,000 $-512,000
Change In Working Capital $12,080,000 $11,638,000 $417,000 $-5,151,000
Change In Other Working Capital $-868,000 $-1,215,000 $-679,000 $305,000
Change In Other Current Liabilities $-1,652,000 $-1,460,000 $5,751,000 $323,000
Change In Other Current Assets $1,421,000 $3,163,000 $-5,530,000 $1,678,000
Change In Payables And Accrued Expense $-3,818,000 $-4,084,000 $-4,032,000 $1,207,000
Change In Accrued Expense $-1,607,000 $-5,089,000 $-3,647,000 $-889,000
Change In Payable $-2,211,000 $1,005,000 $-385,000 $2,096,000
Change In Account Payable $-2,211,000 $1,005,000 $-385,000 $2,096,000
Change In Prepaid Assets $47,000 $667,000 $835,000 $-3,534,000
Change In Inventory $4,463,000 $-324,000 $-5,783,000 $-4,261,000
Change In Receivables $12,487,000 $14,891,000 $9,855,000 $-869,000
Changes In Account Receivables $12,487,000 $14,891,000 $9,855,000 $-869,000
Other Non Cash Items $5,391,000 $2,206,000 $414,000 $1,779,000
Stock Based Compensation $1,043,000 $1,569,000 $2,104,000 $2,068,000
Provisionand Write Offof Assets $2,474,000 $2,508,000 $9,757,000 $1,193,000
Deferred Tax $-443,000 $-69,000 $-709,000 $-165,000
Deferred Income Tax $-443,000 $-69,000 $-709,000 $-165,000
Depreciation Amortization Depletion $3,889,000 $4,115,000 $4,463,000 $4,854,000
Depreciation And Amortization $3,889,000 $4,115,000 $4,463,000 $4,854,000
Amortization Cash Flow $3,474,000 $3,473,000 $3,473,000 -
Amortization Of Intangibles $3,474,000 $3,473,000 $3,473,000 -
Depreciation $415,000 $642,000 $990,000 -
Gain Loss On Sale Of PPE $93,000 $10,000 $158,000 $0
Gain Loss On Sale Of Business $23,000 $174,000 $0 $567,000
Net Income From Continuing Operations $-46,971,000 $-37,050,000 $-43,584,000 $-22,141,000
Repayment Of Debt - $0 $-543,000 $-738,000
Proceeds From Stock Option Exercised - $0 $23,000 $1,257,000
Long Term Debt Payments - $0 $-543,000 $-738,000
Net Business Purchase And Sale - - $0 $-40,000
Purchase Of Business - - $0 $-40,000
Short Term Debt Payments - - - $0
Asset Impairment Charge - - - $0
Net Foreign Currency Exchange Gain Loss - - - $0
Fetched: 2026-02-07